1. Fatty acid-binding proteins 3 and 5 are involved in the initiation of mitochondrial damage in ischemic neurons
   Qingyun Guo et al, 2022, Redox Biology CrossRef
2. Neuroprotective Effect of Phloretin in Rotenone-Induced Mice Model of Parkinson’s Disease: Modulating mTOR-NRF2-p62 Mediated Autophagy-Oxidative Stress Crosstalk
   Shubhendu M. Shirgadwar et al, 2022, JAD CrossRef
3. Rotenone-Induced Model of Parkinson’s Disease: Beyond Mitochondrial Complex I Inhibition
   María Teresa Ibarra-Gutiérrez et al, 2023, Mol Neurobiol CrossRef
4. Sodium butyrate ameliorates gut dysfunction and motor deficits in a mouse model of Parkinson’s disease by regulating gut microbiota
   Yi Zhang et al, 2023, Front. Aging Neurosci. CrossRef
5. Experimental models of chemically induced Parkinson’s disease in zebrafish at the embryonic larval stage: a systematic review
   Paola Briñez-Gallego et al, 2023, Journal of Toxicology and Environmental Health, Part B CrossRef
6. Monoterpenoid Epoxidiol Ameliorates the Pathological Phenotypes of the Rotenone-Induced Parkinson’s Disease Model by Alleviating Mitochondrial Dysfunction
   Yulia Aleksandrova et al, 2023, IJMS CrossRef
7. Neuroprotective Effect of Mangiferin against Parkinson’s Disease through G-Protein-Coupled Receptor-Interacting Protein 1 (GIT1)-Mediated Antioxidant Defense
   Hang Zhou et al, 2023, ACS Chem. Neurosci. CrossRef
8. New insights in animal models of neurotoxicity-induced neurodegeneration
   Coral Sanfeliu et al, 2024, Front. Neurosci. CrossRef
9. The Role of Stinging Nettle (Urtica Dioica L.) in the Management of Rotenone-Induced Parkinson's Disease in Rats
   Emad Albadawi et al, 2024, Tissue and Cell CrossRef
10. Targeting Mitochondrial Complex I Deficiency in MPP+/MPTP-induced Parkinson’s Disease Cell Culture and Mouse Models by Transducing Yeast NDI1 Gene
    Hongzhi Li et al, 2024, Biol Proced Online CrossRef
11. Physical exercise regulates microglia in health and disease
    Alexandra O. Strohm et al, 2024, Front. Neurosci. CrossRef